231: Big deal, little deal, or no deal? A 2024 health policy retrospective

November 19th, 2024  |  40 mins 52 secs

clinical innovation and affordability, physician landscape, provider strategy and financial outlook, value-based care

Drugs, docs, and mandatory payment models. In this episode, host Abby Burns invites Advisory Board experts Gina Lohr, Sarah Roller, and Paul Trigonoplos to unpack three major health policy topics of 2024. The experts explore how these policies are affecting the industry, how the elections outcomes may impact them, and, critically, how much attention leaders need to pay them going forward.

230: Elections results are in: What healthcare leaders need to know

November 12th, 2024  |  45 mins 10 secs

clinical innovation and affordability, leadership, provider strategy and financial outlook

The 2024 elections are over. In this episode, hosts Rachel Woods and Abby Burns invite Advisory Board experts Natalie Trebes and Ben Palmer to break down what healthcare leaders can anticipate under incoming federal and state leadership bodies, what impacts new leadership is likely to have on key issue areas like the ACA, Medicaid, drug pricing, abortion, and more, and what we will be watching for in the days, weeks, and months to come. And, of course, what it all means for you, our listeners.

229: Live from HLTH: What Can’t GLP-1s Do?

November 5th, 2024  |  41 mins 36 secs

clinical innovation and affordability, external guests, provider strategy and financial outlook

In this episode, recorded live from HLTH 2024, host Rae Woods sits down with Calibrate CEO Rob MacNaughton, Real Chemistry President of Transformative Healthcare Markets Rita Glaze-Rowe, and physician founder, Dr. Spencer Nadolsky, to break down both the optimism and pessimism surrounding GLP-1s, as well as their limitations. In a market that is buzzing around the novel medications, these experts suggest a new focus on comprehensive weight management programs.

228: Avoiding ‘pilot purgatory’ in remote patient monitoring

October 29th, 2024  |  23 mins 30 secs

clinical innovation and affordability, provider strategy and financial outlook, tech and ai

In this episode, host Rachel Woods invites Advisory Board experts Lauren Woodrow and Kristin Strubel to unpack the unseen promise of remote patient monitoring (RPM). Together, they explain why most RPM programs aren’t being used to their full potential and share steps leaders can take to optimize their RPM technologies, regardless of what stage of adoption they are in.

227: The changing tide of Medicare Advantage

October 22nd, 2024  |  20 mins 29 secs

physician landscape, provider strategy and financial outlook

Hosts Rachel Woods and Abby Burns sit down with Advisory Board health plan experts Max Hakanson and Chelsea Needham to make sense of the challenges and changes in the Medicare Advantage market.

226: It’s time to double down on operational excellence: Live from Advisory Board’s Strategy Summit

October 15th, 2024  |  41 mins 3 secs

external guests, leadership, provider strategy and financial outlook

In this episode, recorded live at Advisory Board’s 2024 Strategy Summit, guest host Sarah Roller, Advisory Board Managing Director of Physician and Medical Group Research, explores what it takes for organizations to achieve peak operational performance with Dr. Mary Jo Cagle, CEO of Cone Health, and Dr. Cynthia Horner, Chief Medical Officer of Amwell and President of Amwell Medical Group.

225: Patients are back – so why aren't hospital margins?

October 8th, 2024  |  26 mins 18 secs

external guests, provider strategy and financial outlook

In this episode, host Abby Burns invites Advisory Board experts Sebastian Beckmann and Elizabeth Orr to break down why positive volume forecasts may not translate to a healthy financial outlook. Later, Abby invites Optum Advisory expert Alex Kist to share the story of how her team helped one health system unlock differentiated growth using their local and internal enterprise data.

224: The $400M referral problem (and steps to fixing it)

October 1st, 2024  |  24 mins 56 secs

physician landscape, provider strategy and financial outlook

This week, host Rachel (Rae) Woods invites Advisory Board physician experts Eliza Dailey and Colleen Wagner to unpack where referral leakage actually happens and share the real (and relatively easy) steps organizations can take to reduce referral leakage.

223: What would it take for home-based care to take off? With Medically Home's Dr. Matt Richards

September 24th, 2024  |  29 mins 55 secs

clinical innovation and affordability, external guests

This week, host Abby Burns invites Dr. Matthew Richards, Senior Medical Director of home-care enablement company Medically Home, to explore the role that home-base care could play in the future of healthcare, and to unpack the misconceptions that prevent home-based care from playing a larger role in the healthcare ecosystem today.

[Encore] What the industry is (still) getting wrong about value-based care

September 17th, 2024  |  27 mins 25 secs

In this episode, host Rachel Woods invites Advisory Board value-based care expert Daniel Kuzmanovich and Optum Advisory Service's SVP of value-based care, Erik Johnson, to discuss the mindset shifts they think leaders should be making when pursuing a sustainable value-based care strategy.

222: It's not just GLP-1s; here's what comprehensive weight management looks like

September 10th, 2024  |  25 mins 45 secs

clinical innovation and affordability, service lines

In this episode, host Abby Burns invites Advisory Board experts Chloe Bakst, Payton Grimes, and Atticus Raasch to break down how approaching obesity care holistically can help provider leaders avoid pitting services like bariatric surgery and GLP-1s against each other, and instead compound—rather than cannibalize—the impact each service has on patients, clinicians, and the system as a whole.

221: How will health system growth look different in 2025 and beyond?

September 3rd, 2024  |  25 mins 12 secs

provider strategy and financial outlook

In this episode, host Abby Burns invites Advisory Board health system experts Elizabeth Orr and Marisa Nives to break down how different types of health systems are thinking about growth for 2025 and beyond.